© 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.
Sabrina Martucci Johnson, Daré’s President & CEO, Named as One of FiercePharma’s Most Influential People in Biopharma in 2023
Sabrina Martucci Johnson, Daré's President & CEO, Named…
PharmaVoice: Leaders wave a magic wand at pharma’s thorniest issues
PharmaVoice: Leaders wave a magic wand at pharma’s thorniest…
Scrip Asks…What Does 2023 Hold For Biopharma? Part 10: Diversity, Equity And Inclusion (Subscription required)
Scrip Asks…What Does 2023 Hold For Biopharma? Part 10: Diversity,…
San Diego Business Journal: Sabrina Martucci Johnson, Daré’s President and CEO, Named as of San Diego’s Top 50 Most Influential Women Over 50
San Diego Business Journal: Sabrina Martucci Johnson, Daré's…
Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances (Subscription required)
Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic…
Scrip Asks…What Does 2023 Hold For Biopharma? Part 7: Clinical Trial Trends (Subscription required)
Scrip Asks…What Does 2023 Hold For Biopharma? Part 7: Clinical…
HealthLeaders: Daré Bioscience CEO Drives Culture of Transformation in Women’s Health
HealthLeaders: Daré Bioscience CEO Drives Culture of Transformation…
PharmaVoice: What’s top of mind for industry execs at JPM?
PharmaVoice: What’s top of mind for industry execs at JPM?
HealthLeaders: Increased Contraceptive Education Can Help Manage Impact of Roe vs. Wade
July 22, 2022
Endpoints News: ‘We will continue to fight’: Contraceptive companies remain hopeful after House passes bill
July 22, 2022
Endpoints News: After abortion ruling, biotechs behind novel contraceptives say tide is turning on insurance coverage
July 19, 2022
FierceBiotech: Biotech’s women leaders decry US abortion bans: ‘We will not stand by silently’
July 5, 2022
FierceBiotech: ‘Organize. Align’: Women in biotech see Roe v. Wade ruling as a call to action
July 11, 2022